Market Overview

UPDATE: Deutsche Bank Raises PT on Becton, Dickinson and Co. on Strong F1Q13 Sales and EPS

Share:
Related BDX
Earnings Scheduled For May 5, 2016
UPDATE: BD Announces Divestment of Vertebral Augmentation Solutions Business to Stryker; Terms Not Disclosed
Medical Device Makers Crowd Into Big Cap 20 (Investor's Business Daily)

In a report published Wednesday, Deutsche Bank reiterated its Hold rating on Becton, Dickinson and Co. (NYSE: BDX), and raised its price target from $85.00 to $89.00.

Deutsche Bank noted, “F1Q13 sales and EPS were ahead expectations. Sales were up 5.2% ex-FX and included ~10bp from acquisitions and ~50bp benefit from an earlier flu season. BD increased the low end of its constant currency guidance, though FX was the primary driver behind the higher EPS guidance. We were encouraged by the performance of the top line as well as gross margins in the quarter which combined with the higher EPS outlook prompted us to raise our PT to $89 from $85. However, given the relative valuation, we maintain our Hold rating.”

Becton, Dickinson and Co. closed on Tuesday at $87.67.

Latest Ratings for BDX

DateFirmActionFromTo
Feb 2016Deutsche BankUpgradesHoldBuy
Feb 2016CitigroupMaintainsNeutral
Jan 2016Evercore ISI GroupDowngradesBuyHold

View More Analyst Ratings for BDX
View the Latest Analyst Ratings

Posted-In: Deutsche BankAnalyst Color Price Target Analyst Ratings

 

Related Articles (BDX)

View Comments and Join the Discussion!